FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) (“CHS”) announced today that it is expanding its partnership with Mark Cuban Cost Plus Drugs Company, making more ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. LAS VEGAS — Online pharmacy Cost Plus Drugs will be ...

Mark Cuban Cost Plus Drugs has expanded its partnership with GraphiteRx to support the Cost Plus Marketplace for Businesses. The platform combines Cost Plus Drugs’ pricing model with GraphiteRx’s ...

For many Americans, pharmaceutical drugs are too expensive—and thanks to a system of complex and tedious bureaucracy, any effort for meaningful reform has been futile. Cost Plus Drugs wants to change ...

DALLAS, Nov. 6, 2025 /PRNewswire/ -- Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable ...

9amHealth, a virtual cardiometabolic care company, and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), are collaborating to allow 9amHealth to use lower-cost oral meds from Cost Plus Drugs ...

WILMINGTON, Del.--(BUSINESS WIRE)--Truveris, a leading healthcare technology company focused on reducing pharmacy spend, announced today that they are collaborating with Mark Cuban Cost Plus Drug ...

Mark Cuban (center), co-founder of Cost Plus Drugs explains his company's discussions with Humana to develop "direct-to-employer" prescription drug programs that bypass traditional pharmacy benefit ...

Mark Cuban is best known for basketball and billions, but lately, the long-time “Shark Tank” veteran, social media influencer and regular TV personality has been focused on healthcare. He created Cost ...

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...

The rise of more transparent, “Cost Plus” pharmacy models is stirring debate within the pharmaceutical space as smaller players put pressure on the large PBMs. In January 2022, entrepreneur Mark Cuban ...